IFPMA Statement on WTO TRIPS Intellectual Property Waiver

IFPMA Statement on WTO TRIPS Intellectual Property Waiver Geneva, 5 May 2021- The decision of the US administration to support a patent waiver for COVID-19 vaccines is disappointing. We are fully aligned with the goal to ensure COVID-19 vaccines are quickly and equitably shared around the world. But, as we have consistently stated, a waiver…

The digital future of healthcare

The digital future of healthcare In the last year, given the situation brought by the pandemic, the world has seen an increase in the use of digital technology. In healthcare services, digital technology has the capacity to make a difference, and allow to optimize patient care by having the potential to transform research and development…

The future of medicine are Advanced Therapies products

The future of medicine are Advanced Therapies products Drugs or treatments obtained from cells, genes, or tissues are known as Advanced Therapies. These types of therapies are expanding the boundaries of science and addressing unmet health needs. Thus, these products have the promise of changing the course of diseases and enhancing certain cures that already…

Clinical Trials in Times of COVID-19

Clinical Trials in Times of COVID-19 Clinical trials are experimental evaluations of a product, substance, drug, diagnostic or therapeutic technique which, in its research and application to humans, aims to assess its efficacy and safety. Thus, these studies are an essential component of the scientific process, that promotes greater levels of accountability in research, improves…

FIFARMA appoints new Steering committee

FIFARMA appoints new Steering committee Florencia Davel, General Manager, Latin America at Bristol Myers Squibb, was appointed chair of FIFARMA’s Steering Committee for the period 2021-2022. 11 May 2021.- Today, the Latin American Federation of the Pharmaceutical Industry (FIFARMA) announced the appointment of the new Steering Committee members for the period 2021-2022. They will accompany…

Investing in the health sector: lessons learned from the pandemic

Investing in the health sector: lessons learned from the pandemic Investing in health has always been a possibility, but after the pandemic it became a necessity to prevent future crisis. In fact, before COVID-19, countries around the world were actively seeking to reach all populations, to provide better health services and to reduce out-of-pocket spending…

History of Intellectual Property in the industry

History of Intellectual Property in the industry Intellectual property (IP) is one of the most important systems in modern society and one of the least understood, because legislation surrounding it, is complex and difficult to interpret. However, IP is the basis for many sectors to innovate and bet on knowledge and creativity, making it a…

How does Intellectual Property work when collaborating with others in the industry?

How does Intellectual Property work when collaborating with others in the industry? In recent years, and especially during the COVID-19 crisis, collaboration in the health sector has become a fundamental tool for innovation. More specifically, collaboration within the pharmaceutical industry secures funding, provides access to new technologies, helps overcome barriers and strengthens areas of weakness.…